Table 1. Natural history of visual parameters over time.
| Year | Age (y) | SE (D) | BCVA (Snellen) | IOP (mm Hg) | AL (mm) | Diagnosis | Treatment |
| 2017 | 5 | -2.5 | 20/50 | - | 25.15 | Myopia | Lens correction |
| -4.25 | 20/25 | 26.48 | |||||
| 2018 | 6 | -2 | 20/400 | 8 | - | Uveitis | Corticosteroids with CyA |
| -5.75 | 20/25 | 17 | |||||
| 2019 | 7 | -4 | CF/25 cm | 8.5 | 25.89 | CG | Maintenance BZ-TL |
| -8.25 | 20/63 | 23.9 | 28.99 | ||||
| 2020 | 8 | -3 | HM/50 cm | 10.5 | 26.23 | CG | Maintenance BZ-TL |
| -12 | 20/200 | 13.5 | 30.26 | ||||
| 2021 | 9 | -3.5 | 20/400 | 10.7 | 26.81 | CG | Maintenance BZ-TL |
| -10.5 | 20/100 | 14.7 | 30.42 | ||||
| 2022 | 10 | - | LP | 23.7 | 29.25 | CG with RE cataract | RE phacoemulsification; maintenance BZ-TL |
| 20/200 | 17.7 | 33.37 | |||||
| 2023 | 11 | - | HM/BE | 23.0 | 29.81 | CG | LE photocoagulation; maintenance BZ-TL |
| -15.00 | 20/333 | 14.0 | 36.14 |
SE: Spherical equivalent; BCVA: Best corrected visual acuity; IOP: Intraocular pressure; AL: Axial length; CyA: Cyclosporine A; RE: Right eye; LE: Left eye; CG: Choroidal ganglioneuroma; CF: Counting finger; LP: Light perception; HM: Hand motion; BE: Before eye; -: Not available; BZ-TL: Brinzolamide-timolol.